By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


CogState Ltd 

21 Victoria Street, Level 7

Melbourne  Victoria  3000  Australia
Phone: 613-9664-1300 Fax: 613-9664-1301



Company News
CogState Ltd (CGS.AX) Receives Positive FDA Notification Regarding Medical Device Regulatory Submission 7/27/2017 8:41:40 AM
CogState Ltd (CGS.AX) Selected As Preferred Provider To Eli Lilly (LLY)’s Alzheimer’s Disease Platform 5/17/2017 6:44:36 AM
CogState Ltd (CGS.AX) Strengthens Executive Team With Appointment Of Chief Technology Officer 3/17/2017 8:45:35 AM
CogState Ltd (CGS.AX) Announces New Executive Appointments For Clinical Trials And Healthcare Business Units 11/29/2016 11:51:17 AM
CogState Ltd (CGS.AX) And Clinical Ink Deliver Enhanced Tablet-Based eCOA For CNS Clinical Trials 10/25/2016 12:15:07 PM
CogState Ltd (CGS.AX) IPad Cognitive Assessments Selected For Use In Phase IV Observational Study Of Approved Treatments For Prostate Cancer 11/18/2015 7:59:27 AM
CogState Ltd (CGS.AX) Releases Latest Version Of Online Cognitive Screening Solution For Clinical Trials: Precision Recruitment 7/22/2015 1:25:45 PM
CogState Ltd (CGS.AX) Release: Computerized Cognition Test Provides Better Assessment than Observation 8/25/2014 8:06:59 AM
CogState Ltd (CGS.AX) Release: Early Detection Of Alzheimer's Disease Enables Caregivers To Significantly Delay Admission Of Their Loved Ones To Nursing Homes 4/9/2014 10:06:43 AM
CogState Ltd (CGS.AX)'s Technology Chosen For Major Phase 3 Trial Of Alzheimer's Disease Drug 3/25/2014 8:53:49 AM